Importantly, none of the mutants complemented ICL-induced hypersensitivity (Fig. 5c), cell cycle arrest (Fig. 5d), or chromosome fragility (Fig. 5e) of EDC4 KO cells, indicating that all mutations found in breast cancer patients disrupt the function of EDC4 in DNA repair. Here, EDC4 is linked to breast carcinoma.